Pfizer (PFE) Asset Utilization Ratio (2009 - 2026)

Pfizer (PFE) has 18 years of Asset Utilization Ratio data on file, last reported at 0.12 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.12, down 19.34% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.12 (down 19.34% YoY), and the FY2025 annual result was 0.3, up 666.08% from the prior year.
• Asset Utilization Ratio advanced to 0.12 in Q1 2026 per PFE's latest filing, from 0.12 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.67 in Q4 2022 and troughed at 0.03 in Q3 2025.
• A 5-year average of 0.23 and a median of 0.15 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio plunged 91.78% in 2023, then soared 166.17% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.67 in 2022, then plunged by 91.7% to 0.06 in 2023, then soared by 166.21% to 0.15 in 2024, then declined by 20.98% to 0.12 in 2025, then climbed by 1.17% to 0.12 in 2026.
• Business Quant data shows PFE's Asset Utilization Ratio at 0.12 in Q1 2026, 0.12 in Q4 2025, and 0.03 in Q3 2025.